Ritalin OK for most pediatric cancer survivors

07/16/2009 | Reuters

Most childhood cancer survivors do well on Ritalin treatment for attention deficit problems, according to a study in Pediatrics. Researchers said some children, including girls and those with low IQs, should be more closely monitored for side effects. Children who were brain tumor survivors also were more than three times as likely to stop taking the drug because of side effects.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX